We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RAPT market cap is 139.19M. The company's latest EPS is USD -3.3565 and P/E is -1.19.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -31.56M | -28.36M | -33.92M | -33.22M | -32.52M |
Net Income | -29.27M | -25.28M | -31.37M | -30.88M | -30.52M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 5.04M | 3.81M | 1.53M | 0 |
Operating Income | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M |
Net Income | -43M | -52.89M | -69.2M | -83.84M | -116.8M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 248.33M | 220.76M | 199.72M | 173.33M | 155.82M |
Total Liabilities | 27.86M | 21.08M | 26.92M | 26.29M | 24.98M |
Total Equity | 220.47M | 199.68M | 172.8M | 147.04M | 130.84M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 84.6M | 118.97M | 198.64M | 266.21M | 173.33M |
Total Liabilities | 11.48M | 14.79M | 12.26M | 21.04M | 26.29M |
Total Equity | 73.12M | 104.18M | 186.38M | 245.17M | 147.04M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -18.6M | -47.41M | -69.29M | -97.05M | -27.08M |
Investing | 25.31M | 57.75M | 83.49M | 104.13M | 15.89M |
Financing | 116k | 883k | 989k | 1.45M | 9.04M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -35.47M | -40.49M | -61.03M | -70.77M | -97.05M |
Investing | -843k | -87.44M | -81.35M | -45.49M | 104.13M |
Financing | 49.9M | 75.46M | 141.48M | 131.18M | 1.45M |
Market Cap | 139.19M |
Price to Earnings Ratio | -1.19 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.92 |
Price to Book Ratio | 0.94 |
Dividend Yield | - |
Shares Outstanding | 34.8M |
Average Volume (1 week) | 697.38k |
Average Volume (1 Month) | 1.07M |
52 Week Change | -80.68% |
52 Week High | 27.35 |
52 Week Low | 3.88 |
Spread (Intraday) | 0.28 (6.57%) |
Company Name | RAPT Therapeutics Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://www.rapt.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions